Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/31242
Full metadata record
DC FieldValue
dc.contributor.authorBombaça, Ana Cristina S.
dc.contributor.authorViana, Paula G.
dc.contributor.authorSantos, Augusto C. C.
dc.contributor.authorSilva, Thaissa L.
dc.contributor.authorRodrigues, Aline Beatriz M.
dc.contributor.authorGuimarães, Ana Carolina R.
dc.contributor.authorGoulart, Marilia O. F.
dc.contributor.authorSilva Júnior, Eufrânio N. da
dc.contributor.authorMenna-Barreto, Rubem F. S.
dc.date.accessioned2019-01-23T13:01:05Z
dc.date.available2019-01-23T13:01:05Z
dc.date.issued2019
dc.identifier.citationBOMBAÇA. Ana Cristina et al. Mitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of β-lapachone-derived naphthoimidazoles. Free Radical Biology and Medicine, v. 130, p. 408-418, 2019.
dc.identifier.issn0891-5849
dc.identifier.urihttps://www.arca.fiocruz.br/handle/icict/31242
dc.language.isoeng
dc.publisherElsevier
dc.rightsrestricted access
dc.subject.otherTrypanosoma cruzi
dc.subject.otherDoença de Chagas
dc.subject.otherQuimioterapia
dc.subject.otherMitocondria
dc.subject.otherNaftoimidazoles
dc.subject.otherEspécies que reagem ao oxigênio
dc.subject.otherDefesas antioxidantes
dc.titleMitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of β-lapachone-derived naphthoimidazoles
dc.typeArticle
dc.identifier.doi10.1016/j.freeradbiomed.2018.11.012
dc.description.abstractenChagas disease is caused by the hemoflagellate protozoa Trypanosoma cruzi and is one of the most important neglected tropical diseases, especially in Latin American countries, where there is an association between low-income populations and mortality. The nitroderivatives used in current chemotherapy are far from ideal and present severe limitations, justifying the continuous search for alternative drugs. Since the1990s, our group has been investigating the trypanocidal activity of natural naphthoquinones and their derivatives, and three naphthoimidazoles (N1, N2 and N3) derived from β-lapachone were found to be most effective in vitro. Analysis of their mechanism of action via cellular, molecular and proteomic approaches indicates that the parasite mitochondrion contains one of the primary targets of these compounds, trypanothione synthetase (involved in trypanothione production), which is overexpressed after treatment with these compounds. Here, we further evaluated the participation of the mitochondria and reactive oxygen species (ROS) in the anti-T. cruzi action of naphthoimidazoles. Preincubation of epimastigotes and trypomastigotes with antioxidants (α-tocopherol and urate) strongly protected the parasites from the trypanocidal effect of naphthoimidazoles, decreasing the ROS levels produced and reverting the mitochondrial swelling phenotype. The addition of pro-oxidants (menadione and H2O2) before the treatment induced an increase in parasite lysis. Despite the O2 uptake and mitochondrial complex activity being strongly reduced by N1, N2 and N3, urate partially restored the mitochondrial metabolism only in N1-treated parasites. In parallel, MitoTEMPO, a mitochondrial-targeted antioxidant, protected the functionality of the mitochondria in N2- and N3-treated parasites. In addition, the trypanothione reductase activity was remarkably increased after treatment with N1 and N3, and molecular docking demonstrated that these two compounds were positioned in pockets of this enzyme. Based on our findings, the direct impairment of the mitochondrial electron transport chain by N2 and N3 led to an oxidative misbalance, which exacerbated ROS generation and led to parasite death. Although other mechanisms cannot be discounted, mainly in N1-treated parasites, further investigations are required.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal de Minas Gerais. Instituto de Ciências Exatas. Departamento de Química. Belo Horizonte, MG, Brasil.
dc.creator.affilliationUniversidade Federal de Alagoas. Instituto de Química e Biotecnologia. Maceió, AL, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal de Alagoas. Instituto de Química e Biotecnologia. Maceió, AL, Brasil.
dc.creator.affilliationUniversidade Federal de Minas Gerais. Instituto de Ciências Exatas. Departamento de Química. Belo Horizonte, MG, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
dc.subject.enTrypanosoma cruzi
dc.subject.enChagas Disease
dc.subject.enChemotherapy
dc.subject.enNaphthoimidazoles
dc.subject.enReactive oxygen species
dc.subject.enAntioxidant defenses
Appears in Collections:INI - Artigos de Periódicos
IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
anacristina_bombaça_etal_IOC_2018.pdf4.75 MBAdobe PDF    Request a copy



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.